← All organizations

Psyadon Pharma

For profit

Also known as: Ruxton Pharmaceuticals

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 1, 2014

Acquired by Emalex Biosciences on Aug 14, 2018

Timeline

2000s

Jun 1, 2004
Psyadon Pharma— Founded

2010s

Aug 14, 2018
Emalex Biosciences— Acquired By

Drugs by trial phase (2 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

ecopipam

Phase 1 (1 own, 0 via acquisition)

rifampin

Indications

Studied for

Recent trials (9)

NCT02102698Lead sponsorPhase 2Mar 1, 2014
NCT01751802Lead sponsorPhase 3Dec 1, 2012
NCT01408394Lead sponsorPhase 1Aug 1, 2011
NCT01215357Lead sponsorPhase 2Oct 1, 2010
NCT01244633Lead sponsorPhase 1/Phase 2Oct 1, 2010
NCT01065558Lead sponsorPhase 1Feb 1, 2010
NCT00958503Overall official - principal investigatorPhase 1Jul 1, 2007
NCT00958503Reponsible party - principal investigatorPhase 1Jul 1, 2007
NCT00958503Lead sponsorPhase 1Jul 1, 2007

Details

Founded: Germantown, MD, US Jun 1, 2004
Last known activity: Mar 1, 2014